Human Endothelial Cell Activation and Mediator Release in Response to the Bacterial Exotoxins Escherichia coli Hemolysin and Staphylococcal α-Toxin

Journal of Immunology

Volumn 159, Issue 4, 1997, Pages 1909-1916

  Grimminger, Friedrich ^a,c   Rose, Frank ^a   Sibelius, Ulf ^a   Meinhardt, Matthias ^a   Pötzsch, Bernd ^a   Spriestersbach, Reiner ^a   Bhakdi, Sucharit ^b   Suttorp, Norbert ^a   Seeger, Werner ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c Department of Internal Medicine ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL TOXIN; CALCIUM; ESCHERICHIA COLI PROTEIN; HEMOLYSIN; HLYA PROTEIN, E COLI; NITRIC OXIDE; PHOSPHATIDYLINOSITOL; PROSTACYCLIN; STAPHYLOCOCCAL ALPHA-TOXIN; STAPHYLOCOCCUS ALPHA TOXIN; THROMBIN; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL; ARTICLE; BIOSYNTHESIS; CYTOLOGY; DRUG EFFECT; HUMAN; METABOLISM; PHYSIOLOGY; RAT; VASCULAR ENDOTHELIUM;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CALCIUM; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; ESCHERICHIA COLI PROTEINS; HEMOLYSIN PROTEINS; HUMANS; NITRIC OXIDE; PHOSPHATIDYLINOSITOLS; PLATELET ACTIVATING FACTOR; RATS; THROMBIN;

EID: 0031571201     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Moncada, S., R. M. Palmer, and E. A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109.
2. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 63:051.
3. Brenner, B. M., J. L. Troy, and B. J. Ballermann. 1989. Endothelium-dependent vascular responses. J. Clin. Invest. 84:1373.
4. Nies, A. S. 1986. Prostaglandins and the control of the circulation. Clin. Pharmacol. Ther. 39:481.
5. Suttorp, N., C. Galanos, and H. Neuhof. 1987. Endotoxin alters arachidonate metabolism in endothelial cells. Am. J. Physiol. 252:C384.
6. Kilbourn, R. G., S. S. Gross, A. Jubran, J. Adams, Q. W. Griffith, R. Levi, and R. F. Lodato. 1990. N-methyl-L-argine inhibits tumor necrosis factor-induced hypotension: implication for the involvement of nitric oxide. Proc. Natl. Acad. Sci. USA 87:3629.
7. Rees, D. D., R. M. J. Palmer, and S. Moncada. 1989. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. USA 86:3375.
8. Palmer, R. M., D. S. Ashton, and S. Moncada. 1988. Vascular endothelial cells synthesize nitric oxide from L-argine. Nature 333:664.
9. Parker, J. L., and H. R. Adams. 1993. Selective inhibition of endothelium-dependent vasodilator capacity by Escherichia coli endotoxemia. Circ. Res. 72:539.
10. Salvemini, D., R. Korbut, E. Änggard, and J. Vane. 1990. Immediate release of nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA 87:2593.
11. Myers, P. R., T. F. Wright, M. A. Tanner, and H. R. Adams. 1992. EDRF and nitric oxide production in cultured endothelial cells: direct inhibition by E. coli endotoxin. Am. J. Physiol. 262:H710.
12. Bone, R. C. 1994. Gram-positive Organismus and sepsis. Arch. Intern. Med. 154: 26.
13. 2 production in endothelial cells: role of calcium. Am. J. Physiol. 248:C127.
14. Suttorp, N., B. Flöer, H. Schnittler, W. Seeger, and S. Bhakdi. 1990. Effects of Escherichia coli hemolysin on endothelial cell function. Infect. Immun. 58:3796.
15. Suttorp, N., M. Fuhrmann, S. Tannert-Otto, F. Grimminger, and S. Bhakdi. 1993. Pore-forming bacterial toxins potently induce release of nitric oxide in porcine endothelial cells. J. Exp. Med. 178:337.
16. Gille, J., R. A. Swerlick, T. J. Lawley, and S. W. Caughman. 1996. Differential regulation of vascular cell adhesion molecule-1 gene transcription by tumor necrosis factor alpha and interleukin-1 alpha in dermal microvascular endothelial cells. Blood 87:211.
17. Grimminger, F., U. Sibelius, S. Bhakdi, N. Suttorp, and W. Seeger. 1991. Escherichia coli hemolysin is a potent inductor of phosphoinositide hydrolysis and related metabolic responses in human neutrophils. J. Clin. Invest. 88:1531.
18. Bhakdi, S., S. Greulich, M. Muhly, B. Eberspächer, H. Becker, A. Thiele, and F. Hugo. 1989. Potent leukocidal action of Escherichia coli hemolysin mediated by permeabilization of target cell membranes. J. Exp. Med. 169:737.
19. Grimminger, F., C. Scholz, S. Bhakdi, and W. Seeger. 1991. Subhemolytic doses of Escherichia coli hemolysin evoke large quantities of lipoxygenase products in human neutrophils. J. Biol. Chem. 266:14262.
20. Bhakdi, S., and J. Tranum-Jensen. 1987. Damage to mammalian cells by proteins that form transmembrane pores. Rev. Physiol. Biochem. Pharmacol. 107:147.
21. Seeger, W., N. Suttorp, F. Grimminger, and S. Bhakdi. 1993. Bacterial exotoxins and vascular injury. In Pathophysiology of Shock, Sepsis, and Organ Failure. G. Schlag and H. Redl, eds. Springer-Verlag, Berlin Heidelberg, p. 427.
22. Bhakdi, S., and E. Martin. 1991. Superoxide generation by human neutrophils induced by low doses of Escherichia coli hemolysin. Infect. Immun. 59:2955.
23. Bhakdi, S., M. Muhly, U. Mannhardt, F. Hugo, K. Klapettek, C. Mueller-Eckhardt, and L. Roka. 1988. Staphylococcal alpha-toxin promotes blood coagulation via attack on human platelets. J. Exp. Med. 168:527.
24. Jaffe, E. A., R. L. Nachman, C. G. Becker, and C. R. Minick. 1973. Culture of human endothelial cells derived from umbilical veins. J. Clin. Invest. 52:2745.
25. Detmar, M., S. Tenorio, U. Hettmannsperger, Z. Ruszczak, and C. E. Orfanos. 1992. Cytokinc regulation of proliferation and ICAM-1 expression of human dermal microvascular endothelial cells in vitro. J. Invest. Dermatol. 98:147.
26. Pötzsch, B., J. Grulich-Henn, R. Rössing, D. Wille, and G. Müller-Berghaus. 1990. Identification of endothelial cells by specific cell markers. Lab. Invest. 63:841.
27. Pinckard, R. N., R. S. Farr, and D. J. Hanahan. 1979. Physico-chemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils. J. Immunol. 123:1847.
28. Tessner, T. G., J. T. O'Flaherty, and R. L. Wykle. 1989. Stimulation of platelet-activating factor synthesis by a nonmetabolizable bioactive analog of platelet-activating factor and influence of arachidonic acid metabolites. J. Biol. Chem. 264:4794.
29. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:753.
30. Berridge, M. J., R. M. C. Dawson, C. P. Downes, J. P. Heslop, and R. F. Irvine. 1983. Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. Biochem. J. 212:473.
31. Preiss, J., C. R. Loomis, W. R. Bishop, R. Stein, J. E. Niedel, and R. M. Bell. 1985. Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells. J. Biol. Chem. 261:8597.
32. Ishii, K., H. Sheng, T. D. Warner, U. Förstermann, and F. Murad. 1991. A simple and sensitive bioassay method for detection of EDRF with RFL-6 rat lung fibroblasts. Am. J. Physiol. 261:H598.
33. Lum, H., J. L. Aschner, P. G. Phillips, P. W. Fletscher, and A. B. Malik. 1992. Time course of thrombin-induced increase in endothelial permeability: relationship to Ca2+i and inositol polyphosphates. Am. J. Physiol. 263:L219.
34. Carter, A. J., W. G. Eisert, and T. H. Müller. 1989. Thrombin stimulates inositol phosphate accumulation and prostacyclin synthesis in human endothelial cells from umbilical vein but not from omentum. Thromb. Haemost. 61:122.
35. Halldórsson, H., M. Kjeld, and G. Thorgeirsson. 1988. Role of phosphoinositides in the regulation of endothelial prostacyclin production. Arteriosclerosis 8:147.
36. Lambert, T. L., R. S. Kent, and A. R. Whorton. 1986. Bradykinin stimulation of inositol polyphosphate production in porcine aortic endothelial cells. J. Biol. Chem. 263:15288.
37. Tkachuk, V. A., and T. A. Voyno-Yasenetskaya. 1991. Two types of G proteins involved in regulation of phosphoinositide turnover in pulmonary endothelial cells. Am. J. Physiol. (4 Suppl.)261:118.
38. Majerus, P. W., T. M. Conolly, V. S. Bansal, R. C. Inhorn, T. S. Ross, and D. L. Lips. 1988. Inositol phosphates: synthesis and degradation. J. Biol. Chem. 263:3051.
39. Berridge, M. J. 1993. Inositol trisphosphate and calcium signalling. Nature 361: 315.
40. Seeger, W., M. Bauer, and S. Bhakdi. 1984. Staphylococcal alpha-toxin elicits hypertension in isolated rabbit lungs: evidence for thromboxane formation and the role of extracellular calcium. J. Clin. Invest. 74:849.
41. Suttorp, N., W. Seeger, J. Zucker-Raimann, L. Roka, and S. Bhakdi. 1987. Mechanisms of leukotriene generation in polymorphonuclear leukocytes by staphylococcal alpha-toxin. Infect. Immun. 55:104.
42. 2+ in polymorphonuclear leukocytes. Infect. Immun. 56:2228.
43. Dougherty, R. W., P. P. Godfrey, P. C. Hoyle, J. W. Putney Jr., and R. J. Freer. 1984. Secretagogue-induced phosphoinositide metabolism in human leukocytes. Biochem. J. 222:307.
44. Boehm, D. F., R. A. Welch, and I. S. Snyder. 1990. Domains of Escherichia coli hemolysin (HlyA) involved in binding of calcium and erythrocyte membranes. Infect. Immun. 58:1959.
45. Ludwig, A., T. Jarchau, R. Benz, and W. Goebel. 1988. The repeat domain of E. coli hemolysin is responsible for its Ca-dcpendcnt binding to erythrocytes. Mol. Gen. Genet. 214:553.
46. 2+ mobilization in guinea pig neutrophils. J. Biol. Chem. 260:15771.
47. 3+ concentration. Biochem. J. 229:361.
48. Bhakdi, S., and J. Tranum-Jensen. 1991. Alpha-toxin of Staphylococcus aureus. Microbiol. Rev. 55:733.
49. Bhakdi, S., and J. Tranum-Jensen. 1988. Damage to cell membranes by pore-forming bacterial cytolysins. Prog. Allergy 40:1.